×

Reach More Merck Patients Where They Watch

Your patients are watching TV. Are you reaching them?

You missed 54% of your target audience in June 2025.

More than half of the patients who could benefit from Merck’s message never saw it. They are reachable on TV, but untouched by your campaign. Each missed impression it’s a missed opportunity to inform, support, and bring hope to someone who truly needs your brand.

Reaching 37.3 million viewers is meaningful - but it’s only half the story.

Out of 80.9 million reachable viewers, Merck’s June 2025 linear TV campaign captured less than half, leaving millions who fit your ideal profile untouched. These unseen viewers represent lost opportunity and influence. A data-driven TV strategy can close that gap, expanding reach and ensuring your message connects with every potential patient, wherever they are.

Your competitors aren’t reaching them either - half of your target audience remains unserved.

Even leading brands like Opdivo reached only about half of the TV audience in June 2025, according to Nielsen Ad Intel. Staying within traditional TV boundaries limits everyone. The brands that expand their reach first capture the unseen audience - and those viewers become tomorrow’s loyal customers.

With TV+, you can reach up to 90% more of your target audience - without increasing spend.

By uncovering audiences traditional buying misses, TV+ reduces waste and amplifies impact. Every additional viewer drives both awareness and ROI, proving that reach and efficiency can work together when your media strategy is powered by data.

Ready to Reach More Patients?

See how TV+ can transform your pharma marketing with data-driven targeting and cross-channel optimization.

Let Simulmedia help you reach your audience

Get started with TV+ today

🔒 Your information is secure. We respect your privacy.